<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01501968</url>
  </required_header>
  <id_info>
    <org_study_id>CEU 2012-01</org_study_id>
    <nct_id>NCT01501968</nct_id>
  </id_info>
  <brief_title>Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity</brief_title>
  <official_title>Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Siriraj Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ascorbic acid (Vitamin C) could protect renal toxicity from colistin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Renal toxicity due to colistin therapy is common. Ascorbic acid (vitamin C) has been shown to
      prevent colistin associated renal toxicity in animals. This study is conducted to determine
      if acorbic acid can prevent Colistin-Associated Nephrotoxicity.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of patients with Renal toxicity associated with colistin</measure>
    <time_frame>up to 28 days</time_frame>
    <description>Renal toxicity associated with colistin according to RIFLE criteria</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of subjects with cure or improvement</measure>
    <time_frame>up to 28 days</time_frame>
    <description>cure improvement worse death</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Drug Safety</condition>
  <arm_group>
    <arm_group_label>Colistin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Colistimethate sodium 2.5-5mg/kg iv</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colistin + Ascorbic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Colistimethate sodium 2.5-5mg/kg iv and ascorbic acid 2 grams iv every 12 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colistin</intervention_name>
    <description>Colistimethate sodium 2.5-5mg/kg iv per day</description>
    <arm_group_label>Colistin</arm_group_label>
    <other_name>Colistate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colistin + Ascorbic acid</intervention_name>
    <description>Colistimethate sodium 2.5-5mg/kg iv per day and ascorbic acid 2 grams iv q 12 hours</description>
    <arm_group_label>Colistin + Ascorbic acid</arm_group_label>
    <other_name>vitamin c</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years hospitalized patient who needs colistin for therapy of nosocomial
             infection

        Exclusion Criteria:

          -  pregnant woman

          -  lactating mother

          -  allergy to ascorbic acid

          -  receiving non-steroidal antiinflammatory drugs (NSAID), aminoglycosides, vancomycin,
             cisplatin, amphotericin-B

          -  received radiocontrast media within 1 week

          -  renal stone

          -  G-6-PD deficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Visanu Thamlikitkul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine Siriraj Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Visanu Thamlikitkul, MD</last_name>
    <phone>662-419-7783</phone>
    <email>sivth@mahidol.ac.th</email>
  </overall_contact>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Visanu Thamlikitkul, MD</last_name>
      <phone>662-4197783</phone>
      <email>sivth@mahidol.ac.th</email>
    </contact>
    <investigator>
      <last_name>Visanu Thamlikitkul, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <link>
    <url>http://mahidol.ac.th</url>
    <description>mahidol webpage</description>
  </link>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 24, 2011</study_first_submitted>
  <study_first_submitted_qc>December 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2011</study_first_posted>
  <last_update_submitted>December 29, 2011</last_update_submitted>
  <last_update_submitted_qc>December 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colistin</keyword>
  <keyword>ascorbic acid</keyword>
  <keyword>renal toxicity</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Colistin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

